M

Metabloq Pharmaceuticals

10 employees

MetaBloQ is a privately held biotechnology company focused on developing new drugs to block specific metabolic processes in cancer cells.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Biopharma
Health Diagnostics

Date founded

2016

Funding rounds raised

M

Metabloq Pharmaceuticals raised undisclosed on January 1, 2016

Investors: Brandon Capital Partners and Uniseed

FAQ